top of page

Decoding Alzheimer's Disease:
A breakthrough in
Blood-Based Biomarkers

Blood based biomarkers

Our novel AD-associated
Blood-Based Biomarkers

Identified from high-throughput proteomics analysis of healthy vs AD patients' blood samples.

Image by Markus Spiske

Proprietary machine
learning algorithm

Accurately detects the risk of AD in a disease stage dependent manner.

​Proprietary machine learning algorithm
​Proven in clinical trial of 1000+ patients

Proven in clinical trial
of 1000+ patients

Validated in multiple ethnicity patients.

bottom of page